Christian Hopfer
Concepts (401)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Substance-Related Disorders | 37 | 2023 | 971 | 4.600 |
Why?
| Marijuana Abuse | 21 | 2024 | 209 | 4.030 |
Why?
| Cannabis | 12 | 2024 | 382 | 3.880 |
Why?
| Conduct Disorder | 16 | 2023 | 191 | 2.350 |
Why?
| Marijuana Use | 7 | 2024 | 157 | 1.770 |
Why?
| Alcohol Drinking | 16 | 2024 | 652 | 1.740 |
Why?
| Adolescent Behavior | 16 | 2020 | 482 | 1.660 |
Why?
| Marijuana Smoking | 9 | 2022 | 220 | 1.540 |
Why?
| Alcoholism | 17 | 2020 | 717 | 1.330 |
Why?
| Social Environment | 10 | 2014 | 294 | 1.290 |
Why?
| Tobacco Use Disorder | 11 | 2020 | 233 | 1.260 |
Why?
| Adolescent | 90 | 2024 | 18483 | 1.220 |
Why?
| Antisocial Personality Disorder | 15 | 2018 | 159 | 1.190 |
Why?
| Polymorphism, Single Nucleotide | 21 | 2022 | 2062 | 1.170 |
Why?
| Genetic Predisposition to Disease | 16 | 2022 | 2275 | 1.060 |
Why?
| Legislation, Drug | 4 | 2023 | 78 | 0.930 |
Why?
| Twins | 9 | 2024 | 247 | 0.900 |
Why?
| Siblings | 12 | 2020 | 235 | 0.870 |
Why?
| Medical Marijuana | 3 | 2020 | 102 | 0.870 |
Why?
| Analgesics, Opioid | 6 | 2020 | 793 | 0.800 |
Why?
| Smoking | 16 | 2019 | 1487 | 0.800 |
Why?
| Risk-Taking | 7 | 2019 | 319 | 0.800 |
Why?
| Dronabinol | 2 | 2020 | 121 | 0.790 |
Why?
| Genome-Wide Association Study | 14 | 2022 | 1323 | 0.780 |
Why?
| Young Adult | 36 | 2023 | 10799 | 0.760 |
Why?
| Humans | 122 | 2024 | 119032 | 0.750 |
Why?
| Female | 92 | 2023 | 61588 | 0.740 |
Why?
| Opioid-Related Disorders | 5 | 2021 | 417 | 0.740 |
Why?
| Male | 91 | 2023 | 57818 | 0.740 |
Why?
| Diagnostic and Statistical Manual of Mental Disorders | 10 | 2018 | 239 | 0.730 |
Why?
| Colorado | 23 | 2022 | 4196 | 0.730 |
Why?
| Problem Behavior | 2 | 2018 | 85 | 0.730 |
Why?
| Cannabinol | 1 | 2019 | 3 | 0.690 |
Why?
| Diseases in Twins | 4 | 2014 | 181 | 0.670 |
Why?
| Hallucinogens | 1 | 2020 | 74 | 0.670 |
Why?
| Homeless Youth | 3 | 2008 | 15 | 0.660 |
Why?
| Adult | 56 | 2024 | 31525 | 0.650 |
Why?
| Substance Abuse, Intravenous | 3 | 2016 | 80 | 0.640 |
Why?
| Criminals | 1 | 2018 | 31 | 0.640 |
Why?
| Mental Disorders | 8 | 2021 | 939 | 0.630 |
Why?
| Colitis, Ulcerative | 1 | 2019 | 105 | 0.620 |
Why?
| Sexual Behavior | 5 | 2019 | 437 | 0.610 |
Why?
| Prescription Drug Misuse | 1 | 2017 | 38 | 0.600 |
Why?
| Cigarette Smoking | 1 | 2018 | 85 | 0.600 |
Why?
| Receptors, Nicotinic | 7 | 2016 | 295 | 0.590 |
Why?
| Longitudinal Studies | 24 | 2024 | 2513 | 0.590 |
Why?
| Prevalence | 11 | 2022 | 2326 | 0.570 |
Why?
| Genetic Linkage | 3 | 2008 | 321 | 0.560 |
Why?
| Prescription Drug Diversion | 1 | 2016 | 12 | 0.550 |
Why?
| Crohn Disease | 1 | 2019 | 197 | 0.540 |
Why?
| Genotype | 15 | 2019 | 1882 | 0.510 |
Why?
| Motivation | 2 | 2018 | 506 | 0.500 |
Why?
| Body Mass Index | 3 | 2018 | 2092 | 0.480 |
Why?
| Accidents, Traffic | 2 | 2018 | 178 | 0.480 |
Why?
| Inflammatory Bowel Diseases | 1 | 2018 | 290 | 0.470 |
Why?
| Receptors, Dopamine D2 | 4 | 2007 | 87 | 0.470 |
Why?
| Family Health | 1 | 2014 | 201 | 0.440 |
Why?
| Polymorphism, Genetic | 4 | 2016 | 642 | 0.420 |
Why?
| Genetic Variation | 5 | 2022 | 926 | 0.420 |
Why?
| Heroin Dependence | 2 | 2003 | 19 | 0.420 |
Why?
| Cross-Sectional Studies | 9 | 2023 | 4552 | 0.400 |
Why?
| Phenotype | 14 | 2020 | 3004 | 0.370 |
Why?
| Child Abuse | 6 | 2021 | 466 | 0.360 |
Why?
| Substance Abuse Detection | 2 | 2020 | 63 | 0.360 |
Why?
| Urban Population | 2 | 2012 | 409 | 0.360 |
Why?
| Prospective Studies | 9 | 2020 | 6477 | 0.360 |
Why?
| Impulsive Behavior | 4 | 2017 | 105 | 0.350 |
Why?
| Surveys and Questionnaires | 12 | 2019 | 4709 | 0.350 |
Why?
| Nurses, Community Health | 2 | 2019 | 33 | 0.350 |
Why?
| Biological Specimen Banks | 4 | 2019 | 104 | 0.350 |
Why?
| United States | 17 | 2022 | 12557 | 0.350 |
Why?
| Substance Withdrawal Syndrome | 2 | 2019 | 157 | 0.340 |
Why?
| United Kingdom | 3 | 2019 | 236 | 0.340 |
Why?
| Prenatal Care | 3 | 2019 | 252 | 0.340 |
Why?
| Criminal Behavior | 2 | 2018 | 6 | 0.330 |
Why?
| Haplotypes | 5 | 2009 | 473 | 0.330 |
Why?
| Comorbidity | 8 | 2016 | 1527 | 0.330 |
Why?
| Attention Deficit Disorder with Hyperactivity | 5 | 2022 | 366 | 0.320 |
Why?
| House Calls | 2 | 2019 | 133 | 0.320 |
Why?
| Cognition | 4 | 2020 | 1025 | 0.320 |
Why?
| Adolescent Development | 2 | 2019 | 84 | 0.310 |
Why?
| Sex Factors | 10 | 2017 | 1781 | 0.310 |
Why?
| Genetic Association Studies | 4 | 2021 | 371 | 0.300 |
Why?
| Receptors, Cannabinoid | 1 | 2006 | 13 | 0.300 |
Why?
| Health Surveys | 5 | 2012 | 454 | 0.300 |
Why?
| Chromosomes, Human, Pair 9 | 1 | 2006 | 43 | 0.300 |
Why?
| Chromosomes, Human, Pair 3 | 1 | 2006 | 51 | 0.290 |
Why?
| Case-Control Studies | 10 | 2019 | 3173 | 0.290 |
Why?
| Analgesics | 2 | 2020 | 159 | 0.290 |
Why?
| Home Care Services | 2 | 2019 | 217 | 0.290 |
Why?
| Multifactorial Inheritance | 3 | 2022 | 143 | 0.290 |
Why?
| Tandem Mass Spectrometry | 2 | 2020 | 421 | 0.290 |
Why?
| Multigene Family | 3 | 2013 | 200 | 0.280 |
Why?
| Homosexuality | 1 | 2006 | 16 | 0.280 |
Why?
| Mothers | 3 | 2019 | 683 | 0.280 |
Why?
| Drug Prescriptions | 2 | 2018 | 248 | 0.280 |
Why?
| Bisexuality | 1 | 2006 | 16 | 0.280 |
Why?
| Receptors, Dopamine D1 | 1 | 2006 | 27 | 0.280 |
Why?
| Registries | 1 | 2014 | 1810 | 0.270 |
Why?
| Tobacco Use | 2 | 2024 | 58 | 0.270 |
Why?
| Juvenile Delinquency | 4 | 2018 | 103 | 0.270 |
Why?
| Aggression | 4 | 2022 | 184 | 0.260 |
Why?
| Research Subjects | 2 | 2015 | 40 | 0.260 |
Why?
| Substance Abuse Treatment Centers | 3 | 2012 | 42 | 0.250 |
Why?
| Linkage Disequilibrium | 7 | 2021 | 273 | 0.250 |
Why?
| Genomics | 3 | 2020 | 705 | 0.250 |
Why?
| Genome | 1 | 2006 | 278 | 0.250 |
Why?
| Child Behavior Disorders | 3 | 2011 | 129 | 0.240 |
Why?
| Age of Onset | 5 | 2018 | 467 | 0.240 |
Why?
| Obesity | 1 | 2017 | 2751 | 0.240 |
Why?
| Internationality | 2 | 2022 | 152 | 0.240 |
Why?
| Interview, Psychological | 4 | 2013 | 93 | 0.230 |
Why?
| Alleles | 8 | 2018 | 832 | 0.230 |
Why?
| Heroin | 1 | 2003 | 19 | 0.230 |
Why?
| Adoption | 1 | 2003 | 38 | 0.230 |
Why?
| Genetic Loci | 3 | 2022 | 281 | 0.230 |
Why?
| Gene Frequency | 6 | 2016 | 513 | 0.230 |
Why?
| Narcotics | 1 | 2003 | 50 | 0.220 |
Why?
| Child | 22 | 2022 | 19137 | 0.220 |
Why?
| Nerve Tissue Proteins | 5 | 2013 | 551 | 0.220 |
Why?
| Models, Genetic | 6 | 2010 | 595 | 0.220 |
Why?
| Serotonin Plasma Membrane Transport Proteins | 2 | 2016 | 73 | 0.210 |
Why?
| Incidence | 4 | 2018 | 2424 | 0.210 |
Why?
| Risk Factors | 11 | 2022 | 9003 | 0.200 |
Why?
| Age Factors | 6 | 2014 | 2995 | 0.200 |
Why?
| Public Health | 1 | 2006 | 450 | 0.200 |
Why?
| Attention Deficit and Disruptive Behavior Disorders | 2 | 2013 | 56 | 0.190 |
Why?
| Cannabinoid Receptor Agonists | 1 | 2020 | 30 | 0.190 |
Why?
| Sleep Initiation and Maintenance Disorders | 1 | 2022 | 118 | 0.180 |
Why?
| Twins, Monozygotic | 4 | 2010 | 214 | 0.180 |
Why?
| Depression | 3 | 2022 | 1137 | 0.180 |
Why?
| Monoamine Oxidase | 2 | 2013 | 25 | 0.180 |
Why?
| Health Risk Behaviors | 1 | 2019 | 13 | 0.180 |
Why?
| Pain, Postoperative | 2 | 2019 | 211 | 0.180 |
Why?
| Autistic Disorder | 1 | 2022 | 168 | 0.180 |
Why?
| Nausea | 1 | 2020 | 107 | 0.180 |
Why?
| Maternal Health | 1 | 2019 | 45 | 0.180 |
Why?
| Behavior, Addictive | 1 | 2020 | 77 | 0.170 |
Why?
| Minisatellite Repeats | 1 | 2019 | 38 | 0.170 |
Why?
| Physician Incentive Plans | 1 | 2018 | 6 | 0.170 |
Why?
| HIV Infections | 1 | 2013 | 2461 | 0.170 |
Why?
| Expressed Emotion | 1 | 2018 | 20 | 0.170 |
Why?
| Multimodal Imaging | 1 | 2019 | 100 | 0.170 |
Why?
| Calcium-Transporting ATPases | 1 | 2018 | 35 | 0.170 |
Why?
| Mortality, Premature | 1 | 2018 | 13 | 0.170 |
Why?
| Chromatography, Liquid | 1 | 2020 | 355 | 0.160 |
Why?
| Pregnancy | 5 | 2022 | 5694 | 0.160 |
Why?
| Digestive System Surgical Procedures | 1 | 2019 | 91 | 0.160 |
Why?
| Feeding and Eating Disorders | 1 | 2020 | 125 | 0.160 |
Why?
| Cannabinoids | 2 | 2017 | 115 | 0.160 |
Why?
| Analgesics, Non-Narcotic | 1 | 2019 | 116 | 0.150 |
Why?
| Urine | 1 | 2017 | 59 | 0.150 |
Why?
| Suicide | 2 | 2021 | 500 | 0.150 |
Why?
| Receptors, Opioid, mu | 2 | 2015 | 52 | 0.150 |
Why?
| Biomedical Research | 2 | 2014 | 612 | 0.150 |
Why?
| Bioethics | 1 | 2017 | 13 | 0.150 |
Why?
| Middle Aged | 11 | 2019 | 27627 | 0.150 |
Why?
| Infant, Newborn | 4 | 2020 | 5256 | 0.150 |
Why?
| Unsafe Sex | 2 | 2016 | 57 | 0.150 |
Why?
| Physicians, Family | 1 | 2018 | 206 | 0.150 |
Why?
| Depressive Disorder, Major | 2 | 2020 | 303 | 0.150 |
Why?
| Neuropsychological Tests | 2 | 2020 | 1032 | 0.150 |
Why?
| Counseling | 1 | 2020 | 353 | 0.150 |
Why?
| Administration, Oral | 1 | 2019 | 756 | 0.140 |
Why?
| Mental Health | 1 | 2022 | 568 | 0.140 |
Why?
| Brain | 2 | 2019 | 2490 | 0.140 |
Why?
| Lipids | 1 | 2020 | 608 | 0.140 |
Why?
| Receptors, Metabotropic Glutamate | 1 | 2016 | 35 | 0.140 |
Why?
| Gene-Environment Interaction | 2 | 2020 | 201 | 0.140 |
Why?
| Self Report | 2 | 2018 | 699 | 0.140 |
Why?
| Drug Storage | 1 | 2016 | 59 | 0.140 |
Why?
| Patient Admission | 2 | 2012 | 177 | 0.140 |
Why?
| Mental Competency | 1 | 2015 | 27 | 0.140 |
Why?
| Brain Mapping | 1 | 2019 | 532 | 0.130 |
Why?
| Interviews as Topic | 3 | 2007 | 599 | 0.130 |
Why?
| Plasma | 1 | 2017 | 224 | 0.130 |
Why?
| Surgical Procedures, Operative | 1 | 2018 | 215 | 0.130 |
Why?
| Drug Overdose | 2 | 2018 | 294 | 0.130 |
Why?
| Neuroimaging | 1 | 2017 | 256 | 0.130 |
Why?
| Image Processing, Computer-Assisted | 1 | 2019 | 710 | 0.130 |
Why?
| Life Change Events | 1 | 2016 | 134 | 0.130 |
Why?
| Exploratory Behavior | 2 | 2013 | 90 | 0.130 |
Why?
| Informed Consent | 1 | 2015 | 163 | 0.130 |
Why?
| Automobile Driving | 1 | 2016 | 128 | 0.130 |
Why?
| Pregnancy Complications | 1 | 2019 | 448 | 0.130 |
Why?
| Patient Satisfaction | 1 | 2018 | 610 | 0.120 |
Why?
| Twins, Dizygotic | 3 | 2010 | 182 | 0.120 |
Why?
| Proteomics | 1 | 2020 | 876 | 0.120 |
Why?
| Medicine | 1 | 2016 | 106 | 0.120 |
Why?
| Cohort Studies | 6 | 2021 | 5117 | 0.120 |
Why?
| Practice Patterns, Physicians' | 3 | 2019 | 1200 | 0.120 |
Why?
| Netherlands | 1 | 2014 | 62 | 0.120 |
Why?
| Genetic Testing | 1 | 2016 | 389 | 0.120 |
Why?
| Regression Analysis | 3 | 2019 | 984 | 0.120 |
Why?
| Time Factors | 3 | 2019 | 6414 | 0.120 |
Why?
| Aged | 5 | 2018 | 19661 | 0.120 |
Why?
| Receptors, GABA-A | 1 | 2014 | 89 | 0.110 |
Why?
| Temperament | 1 | 2013 | 44 | 0.110 |
Why?
| Conflict of Interest | 1 | 2014 | 120 | 0.110 |
Why?
| Emotions | 2 | 2021 | 495 | 0.110 |
Why?
| Condoms | 1 | 2013 | 110 | 0.110 |
Why?
| Patient Safety | 1 | 2016 | 281 | 0.110 |
Why?
| Severity of Illness Index | 2 | 2019 | 2674 | 0.110 |
Why?
| Family Conflict | 1 | 2012 | 37 | 0.100 |
Why?
| Receptors, Oxytocin | 1 | 2012 | 25 | 0.100 |
Why?
| Socioeconomic Factors | 2 | 2013 | 1129 | 0.100 |
Why?
| Sexual Partners | 1 | 2013 | 159 | 0.100 |
Why?
| Family Relations | 1 | 2012 | 85 | 0.100 |
Why?
| Educational Status | 1 | 2013 | 437 | 0.100 |
Why?
| Multivariate Analysis | 2 | 2012 | 1474 | 0.100 |
Why?
| Ethanol | 2 | 2012 | 575 | 0.090 |
Why?
| Psychometrics | 3 | 2009 | 631 | 0.090 |
Why?
| Dizziness | 1 | 2010 | 70 | 0.090 |
Why?
| Pentachlorophenol | 1 | 1990 | 22 | 0.090 |
Why?
| Logistic Models | 4 | 2019 | 1901 | 0.090 |
Why?
| Hospitalization | 1 | 2019 | 1785 | 0.090 |
Why?
| Biomarkers | 1 | 2020 | 3590 | 0.090 |
Why?
| Magnetic Resonance Imaging | 2 | 2019 | 3175 | 0.090 |
Why?
| Models, Statistical | 2 | 2010 | 636 | 0.090 |
Why?
| Receptor, Cannabinoid, CB1 | 1 | 2009 | 28 | 0.090 |
Why?
| Sample Size | 2 | 2022 | 133 | 0.090 |
Why?
| Suicidal Ideation | 3 | 2021 | 400 | 0.090 |
Why?
| Genetic Markers | 2 | 2007 | 348 | 0.090 |
Why?
| Models, Theoretical | 1 | 2013 | 556 | 0.080 |
Why?
| Taq Polymerase | 2 | 2006 | 10 | 0.080 |
Why?
| Child Abuse, Sexual | 1 | 2009 | 82 | 0.080 |
Why?
| Retrospective Studies | 8 | 2021 | 12990 | 0.080 |
Why?
| Primary Health Care | 1 | 2018 | 1560 | 0.080 |
Why?
| Emergency Service, Hospital | 1 | 2019 | 1864 | 0.080 |
Why?
| Quality of Life | 1 | 2019 | 2369 | 0.080 |
Why?
| Disruptive, Impulse Control, and Conduct Disorders | 1 | 2007 | 7 | 0.080 |
Why?
| Stress, Psychological | 1 | 2016 | 976 | 0.080 |
Why?
| Environment | 4 | 2012 | 346 | 0.080 |
Why?
| Methylphenidate | 2 | 2004 | 36 | 0.080 |
Why?
| Deoxyribonucleases, Type II Site-Specific | 1 | 2007 | 17 | 0.080 |
Why?
| Family | 4 | 2016 | 587 | 0.080 |
Why?
| Polymorphism, Restriction Fragment Length | 1 | 2007 | 64 | 0.080 |
Why?
| Statistics as Topic | 1 | 2008 | 307 | 0.070 |
Why?
| Risk | 2 | 2020 | 854 | 0.070 |
Why?
| 3' Untranslated Regions | 1 | 2007 | 142 | 0.070 |
Why?
| Fathers | 1 | 2006 | 47 | 0.070 |
Why?
| Child of Impaired Parents | 1 | 2006 | 42 | 0.070 |
Why?
| Microsatellite Repeats | 1 | 2006 | 143 | 0.070 |
Why?
| Cheek | 1 | 2006 | 16 | 0.070 |
Why?
| Schizophrenia | 2 | 2022 | 501 | 0.070 |
Why?
| Lysergic Acid Diethylamide | 1 | 2006 | 2 | 0.070 |
Why?
| Social Facilitation | 1 | 2006 | 9 | 0.070 |
Why?
| Sodium Oxybate | 1 | 2006 | 5 | 0.070 |
Why?
| N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2006 | 10 | 0.070 |
Why?
| Poverty | 2 | 2019 | 444 | 0.070 |
Why?
| Central Nervous System Stimulants | 2 | 2004 | 142 | 0.070 |
Why?
| Alcohol-Related Disorders | 1 | 2007 | 111 | 0.070 |
Why?
| Genetics, Population | 1 | 2007 | 207 | 0.070 |
Why?
| Parents | 2 | 2004 | 1212 | 0.070 |
Why?
| Parenting | 1 | 2009 | 252 | 0.070 |
Why?
| Protein Kinase C | 1 | 2007 | 297 | 0.070 |
Why?
| Religion | 1 | 2006 | 68 | 0.070 |
Why?
| Methamphetamine | 1 | 2006 | 51 | 0.070 |
Why?
| Suicide, Attempted | 1 | 2008 | 316 | 0.060 |
Why?
| Beta Rhythm | 1 | 2004 | 11 | 0.060 |
Why?
| Ketamine | 1 | 2006 | 93 | 0.060 |
Why?
| Universities | 1 | 2007 | 347 | 0.060 |
Why?
| Pain Management | 2 | 2019 | 293 | 0.060 |
Why?
| Marriage | 1 | 2004 | 109 | 0.060 |
Why?
| Data Interpretation, Statistical | 3 | 2010 | 336 | 0.060 |
Why?
| Drug Tolerance | 1 | 2003 | 78 | 0.060 |
Why?
| Genome, Human | 2 | 2020 | 386 | 0.060 |
Why?
| Infant | 3 | 2021 | 8295 | 0.050 |
Why?
| Membrane Transport Proteins | 1 | 2003 | 137 | 0.050 |
Why?
| Loneliness | 1 | 2022 | 29 | 0.050 |
Why?
| Europe | 1 | 2022 | 356 | 0.050 |
Why?
| Predictive Value of Tests | 2 | 2021 | 1868 | 0.050 |
Why?
| Sensitivity and Specificity | 2 | 2021 | 1795 | 0.050 |
Why?
| Models, Psychological | 2 | 2016 | 298 | 0.050 |
Why?
| Electroencephalography | 1 | 2003 | 387 | 0.050 |
Why?
| Personality Assessment | 2 | 2013 | 78 | 0.050 |
Why?
| Calibration | 1 | 2021 | 135 | 0.050 |
Why?
| Membrane Glycoproteins | 1 | 2003 | 446 | 0.050 |
Why?
| Proportional Hazards Models | 2 | 2018 | 1125 | 0.050 |
Why?
| Follow-Up Studies | 2 | 2019 | 4596 | 0.050 |
Why?
| Bayes Theorem | 1 | 2021 | 344 | 0.050 |
Why?
| Polymerase Chain Reaction | 2 | 2014 | 1012 | 0.040 |
Why?
| Bipolar Disorder | 1 | 2022 | 209 | 0.040 |
Why?
| Minnesota | 1 | 2020 | 137 | 0.040 |
Why?
| Interrupted Time Series Analysis | 1 | 2019 | 45 | 0.040 |
Why?
| Infant, Small for Gestational Age | 1 | 2019 | 73 | 0.040 |
Why?
| Dangerous Behavior | 1 | 2018 | 20 | 0.040 |
Why?
| Diffusion Magnetic Resonance Imaging | 1 | 2019 | 90 | 0.040 |
Why?
| Drug Utilization Review | 1 | 2019 | 60 | 0.040 |
Why?
| Signal Processing, Computer-Assisted | 1 | 2019 | 140 | 0.040 |
Why?
| Electronic Mail | 1 | 2018 | 55 | 0.040 |
Why?
| Safety-net Providers | 1 | 2019 | 96 | 0.040 |
Why?
| Atmospheric Pressure | 1 | 2017 | 19 | 0.040 |
Why?
| Factor Analysis, Statistical | 2 | 2010 | 270 | 0.040 |
Why?
| Statistics, Nonparametric | 2 | 2012 | 403 | 0.040 |
Why?
| Preoperative Period | 1 | 2018 | 110 | 0.040 |
Why?
| Limit of Detection | 1 | 2017 | 55 | 0.040 |
Why?
| Child, Preschool | 2 | 2022 | 9493 | 0.040 |
Why?
| Epidemics | 1 | 2018 | 70 | 0.040 |
Why?
| Treatment Outcome | 2 | 2019 | 9346 | 0.040 |
Why?
| Executive Function | 1 | 2021 | 391 | 0.040 |
Why?
| Transcriptome | 1 | 2022 | 756 | 0.040 |
Why?
| Pregnancy Outcome | 1 | 2019 | 349 | 0.040 |
Why?
| Postoperative Period | 1 | 2018 | 309 | 0.040 |
Why?
| Gene Expression | 2 | 2016 | 1492 | 0.040 |
Why?
| Psychiatric Status Rating Scales | 2 | 2010 | 499 | 0.040 |
Why?
| Chromosome Mapping | 2 | 2008 | 510 | 0.040 |
Why?
| California | 1 | 2017 | 382 | 0.040 |
Why?
| Cause of Death | 1 | 2018 | 380 | 0.040 |
Why?
| Mortality | 1 | 2018 | 299 | 0.040 |
Why?
| Nicotine | 2 | 2010 | 276 | 0.040 |
Why?
| CD56 Antigen | 1 | 2016 | 34 | 0.040 |
Why?
| Violence | 1 | 2018 | 218 | 0.030 |
Why?
| Quality Control | 1 | 2016 | 159 | 0.030 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2017 | 490 | 0.030 |
Why?
| Anxiety | 1 | 2022 | 846 | 0.030 |
Why?
| Potassium Channels | 1 | 2016 | 123 | 0.030 |
Why?
| Reward | 1 | 2017 | 209 | 0.030 |
Why?
| Sleep | 1 | 2021 | 660 | 0.030 |
Why?
| Thoracic Surgical Procedures | 1 | 2016 | 64 | 0.030 |
Why?
| Heterozygote | 1 | 2016 | 262 | 0.030 |
Why?
| Practice Guidelines as Topic | 1 | 2003 | 1440 | 0.030 |
Why?
| Psychology, Adolescent | 1 | 2015 | 63 | 0.030 |
Why?
| Cell Adhesion Molecules | 1 | 2016 | 180 | 0.030 |
Why?
| Likelihood Functions | 1 | 2015 | 136 | 0.030 |
Why?
| Sexually Transmitted Diseases | 1 | 2016 | 155 | 0.030 |
Why?
| Aging | 1 | 2004 | 1677 | 0.030 |
Why?
| Demography | 1 | 2015 | 274 | 0.030 |
Why?
| Cesarean Section | 1 | 2016 | 165 | 0.030 |
Why?
| Disclosure | 1 | 2014 | 102 | 0.030 |
Why?
| Arsenites | 1 | 1993 | 4 | 0.030 |
Why?
| Arsenic Poisoning | 1 | 1993 | 8 | 0.030 |
Why?
| Risk Assessment | 2 | 2015 | 3057 | 0.030 |
Why?
| Arsenicals | 1 | 1993 | 26 | 0.030 |
Why?
| Chelating Agents | 1 | 1993 | 74 | 0.030 |
Why?
| Cotinine | 1 | 2013 | 76 | 0.030 |
Why?
| Gluconeogenesis | 1 | 1993 | 66 | 0.030 |
Why?
| Academic Medical Centers | 1 | 2016 | 422 | 0.030 |
Why?
| Databases, Factual | 1 | 2018 | 1231 | 0.030 |
Why?
| Child Behavior | 2 | 2005 | 212 | 0.030 |
Why?
| Students | 1 | 2017 | 509 | 0.030 |
Why?
| Kidney Tubules | 1 | 1993 | 128 | 0.030 |
Why?
| Psychological Theory | 1 | 2013 | 96 | 0.030 |
Why?
| Privacy | 1 | 2012 | 31 | 0.030 |
Why?
| Probability | 1 | 2013 | 305 | 0.030 |
Why?
| Carrier Proteins | 1 | 2016 | 726 | 0.030 |
Why?
| Pedigree | 1 | 2013 | 485 | 0.030 |
Why?
| Antidotes | 1 | 1993 | 126 | 0.030 |
Why?
| Software | 1 | 2016 | 613 | 0.030 |
Why?
| Disease Progression | 1 | 2018 | 2490 | 0.020 |
Why?
| Attitude of Health Personnel | 1 | 2018 | 993 | 0.020 |
Why?
| Exercise | 1 | 2021 | 1657 | 0.020 |
Why?
| Reproducibility of Results | 2 | 2009 | 2874 | 0.020 |
Why?
| Pleasure | 1 | 2010 | 18 | 0.020 |
Why?
| Sensation | 1 | 2010 | 43 | 0.020 |
Why?
| Chromatography, Gas | 1 | 1990 | 31 | 0.020 |
Why?
| Prognosis | 1 | 2018 | 3443 | 0.020 |
Why?
| Rats, Inbred Strains | 1 | 1990 | 394 | 0.020 |
Why?
| Membrane Proteins | 1 | 2016 | 1056 | 0.020 |
Why?
| Patient Discharge | 1 | 2016 | 794 | 0.020 |
Why?
| Cooperative Behavior | 1 | 2012 | 408 | 0.020 |
Why?
| Negotiating | 1 | 2009 | 25 | 0.020 |
Why?
| Psychological Tests | 1 | 2010 | 129 | 0.020 |
Why?
| Molecular Structure | 1 | 1990 | 459 | 0.020 |
Why?
| Epistasis, Genetic | 1 | 2009 | 73 | 0.020 |
Why?
| Personality Inventory | 1 | 2009 | 134 | 0.020 |
Why?
| Mouth Mucosa | 1 | 2007 | 82 | 0.020 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 982 | 0.020 |
Why?
| Parent-Child Relations | 1 | 2009 | 232 | 0.020 |
Why?
| Odds Ratio | 1 | 2009 | 996 | 0.020 |
Why?
| Analysis of Variance | 1 | 2009 | 1295 | 0.020 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 770 | 0.020 |
Why?
| Rats | 2 | 1993 | 5394 | 0.020 |
Why?
| Confidence Intervals | 1 | 2006 | 324 | 0.020 |
Why?
| Linear Models | 1 | 2007 | 827 | 0.020 |
Why?
| Reference Values | 1 | 2006 | 775 | 0.020 |
Why?
| Aged, 80 and over | 1 | 2016 | 6562 | 0.020 |
Why?
| Research Design | 1 | 2009 | 969 | 0.010 |
Why?
| Frontal Lobe | 1 | 2004 | 148 | 0.010 |
Why?
| Schools | 1 | 2006 | 411 | 0.010 |
Why?
| Dopamine Plasma Membrane Transport Proteins | 1 | 2003 | 40 | 0.010 |
Why?
| Chi-Square Distribution | 1 | 2004 | 525 | 0.010 |
Why?
| Housing | 1 | 2004 | 123 | 0.010 |
Why?
| Family Characteristics | 1 | 2004 | 156 | 0.010 |
Why?
| Attention | 1 | 2004 | 408 | 0.010 |
Why?
| Transcription, Genetic | 1 | 2007 | 1323 | 0.010 |
Why?
| Algorithms | 1 | 2008 | 1543 | 0.010 |
Why?
| DNA | 1 | 2007 | 1388 | 0.010 |
Why?
| Double-Blind Method | 1 | 2003 | 1687 | 0.010 |
Why?
| Cognition Disorders | 1 | 2003 | 529 | 0.010 |
Why?
| Arsenates | 1 | 1993 | 1 | 0.010 |
Why?
| Unithiol | 1 | 1993 | 2 | 0.010 |
Why?
| Dimercaprol | 1 | 1993 | 7 | 0.010 |
Why?
| Succimer | 1 | 1993 | 4 | 0.010 |
Why?
| Arsenic | 1 | 1993 | 40 | 0.010 |
Why?
| Drug Evaluation, Preclinical | 1 | 1993 | 180 | 0.010 |
Why?
| Mice, Inbred Strains | 1 | 1993 | 405 | 0.010 |
Why?
| Animals | 2 | 1993 | 33399 | 0.010 |
Why?
| In Vitro Techniques | 1 | 1993 | 1096 | 0.010 |
Why?
| Rats, Sprague-Dawley | 1 | 1993 | 2478 | 0.000 |
Why?
| Mice | 1 | 1993 | 15528 | 0.000 |
Why?
|
|
Hopfer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|